Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
CALL
Gilead Sciences
GILD
$172B
| $416K | ﹤0.01% |
5,400
| – | – |
|
4002
Tenaris
TS
$27B
| $416K | ﹤0.01% |
13,861
+6,729
| +94% | +$187K |
|
|
CIM
4003
Chimera Investment
CIM
$988M
| $415K | ﹤0.01% |
23,981
+4,016
| +20% | +$64K |
|
4004
NuScale Power
SMR
$3.85B
| $414K | ﹤0.01% |
60,771
+7,473
| +14% | +$60.6K |
|
|
IMGN
4005
DELISTED
Immunogen Inc
IMGN
| $413K | ﹤0.01% |
21,891
-41,041
| -65% | -$485K |
|
4006
Amplify Travel Tech ETF
AWAY
$32.6M
| $412K | ﹤0.01% |
24,207
+19,103
| +374% | +$325K |
|
4007
Astec Industries
ASTE
$997M
| $411K | ﹤0.01% |
9,057
+2,234
| +33% | +$92.1K |
|
|
CNCR
4008
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
| $411K | ﹤0.01% |
31,818
+13,403
| +73% | +$176K |
|
|
GOOD
4009
Gladstone Commercial Corp
GOOD
$626M
| $411K | ﹤0.01% |
33,272
+3,301
| +11% | +$39.6K |
|
|
MYD
4010
DELISTED
BlackRock MuniYield Fund
MYD
| $411K | ﹤0.01% |
39,357
-7,503
| -16% | -$78.2K |
|
|
VTYX
4011
DELISTED
Ventyx Biosciences
VTYX
| $411K | ﹤0.01% |
12,553
+11,159
| +801% | +$385K |
|
4012
Adient
ADNT
$1.57B
| $410K | ﹤0.01% |
10,712
+5,194
| +94% | +$192K |
|
4013
Genco Shipping & Trading
GNK
$1.15B
| $410K | ﹤0.01% |
29,198
-50,873
| -64% | -$731K |
|
4014
Columbia Research Enhanced Core ETF
RECS
$6.1B
| $410K | ﹤0.01% |
+15,855
| New | +$390K |
|
|
HIX
4015
Western Asset High Income Fund II
HIX
$354M
| $408K | ﹤0.01% |
83,619
+1,135
| +1% | +$5.4K |
|
4016
Invesco AI and Next Gen Software ETF
IGPT
$1.21B
| $408K | ﹤0.01% |
11,361
-7,839
| -41% | -$265K |
|
4017
Utah Medical Products
UTMD
$226M
| $408K | ﹤0.01% |
4,377
+51
| +1% | +$4.81K |
|
4018
SLM Corp
SLM
$5.27B
| $407K | ﹤0.01% |
24,949
+4,316
| +21% | +$65.7K |
|
4019
TPG
TPG
$8.51B
| $406K | ﹤0.01% |
13,879
-1,099
| -7% | -$30.8K |
|
4020
Alight
ALIT
$372M
| $405K | ﹤0.01% |
2,191
+986
| +82% | +$175K |
|
4021
Howard Hughes
HHH
$3.98B
| $405K | ﹤0.01% |
5,390
-21,913
| -80% | -$1.59M |
|
4022
W&T Offshore
WTI
$554M
| $405K | ﹤0.01% |
104,816
+19,560
| +23% | +$84.1K |
|
4023
RadNet
RDNT
$6.01B
| $404K | ﹤0.01% |
12,384
+6,834
| +123% | +$199K |
|
4024
Remitly
RELY
$5.54B
| $404K | ﹤0.01% |
21,401
-447
| -2% | -$8.12K |
|
4025
Sanmina
SANM
$11.3B
| $404K | ﹤0.01% |
6,695
+2,512
| +60% | +$138K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.